Hong Kong Stocks Midday Summary: Hang Seng Index Edges Up 0.07% as Healthcare Sector Leads Gains

Stock News12:07

The Hang Seng Index nudged up 0.07%, adding 17 points to reach 25,457, while the Hang Seng Tech Index rose 0.30%. Total turnover in the Hong Kong morning session reached 132 billion Hong Kong dollars.

The Hang Seng Innovative Drug Index climbed over 2.6%, and the Hang Seng Biotech Index gained more than 2.5%. Among notable movers, 派格生物医药-B (02565) surged over 8%, 君实生物 (01877) advanced more than 7%, and 石药集团 (01093) rose over 5%. 剂泰科技-P (07666) jumped over 5%, extending its winning streak to five consecutive sessions, as AI pharmaceutical cross-border collaboration projects accelerate, positioning the company to benefit from industry evolution. 长风药业 (02652) gained over 4% after completing the placement of 21.7477 million new H-shares, with ICF001 potentially filling a clinical gap in the treatment of PH-ILD. 布鲁可 (00325) surged 15% on strong volume, with both first-half revenue and profit growing over 30% year-on-year. 耐世特 (01316) rose over 11% following its results, as mid-term profit attributable to equity holders increased 35.17%, and the company officially launched HMDD. 华勤技术 (03296) advanced over 8%, as major cloud providers increase capital expenditure, and institutions view domestic computing power substitution entering an acceleration phase. 亚博科技控股 (08279) gained another 10% after announcing plans to rename and transfer to a main board listing, while its subsidiary TGX established a joint venture with the Hong Kong Gold Exchange. 三环集团 (06951) rose over 12% to a record high since listing, expected to benefit from the spillover effect of MLCC orders. 智谱 (02513) climbed over 5% after being included in the MSCI China Index, effective at the end of the month. MINIMAX-W (00100) added another 6%, having recently been admitted to the Stock Connect and included in indices such as the Hong Kong Stock Exchange Technology 100. 新秀丽 (01910) rose over 4% after proposing to acquire an 85% stake in the parent company of BÉIS for $178 million. ASMPT (00522) gained another 5%, with second-quarter results and third-quarter guidance both significantly exceeding expectations, and the book-to-bill ratio remaining at a five-year high. 中国铝业 (02600) fell over 5% as aluminum prices retreated, pressured by expectations of resumed production in the Middle East. 德林国际 (01126) dropped over 11% after forecasting a 25% to 35% decline in first-half net profit.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment